Lower frequencies of TP53 mutations that usually show a positive correlation with higher mutational burden have been reported for EBV-positive NPC, GC, BL and PTLD [105,107,108,109,110,111] despite that the p53 pathway is frequently deregulated in these diseases [110]. The gene discussed is TP53; the disease is post-transplant lymphoproliferative disease.